{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T13:00:28Z","timestamp":1773666028192,"version":"3.50.1"},"reference-count":47,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.ad.2012.10.022","type":"journal-article","created":{"date-parts":[[2013,3,26]],"date-time":"2013-03-26T09:54:12Z","timestamp":1364291652000},"page":"328-346","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Penfigoide ampolloso: gu\u00eda de manejo pr\u00e1ctico"],"prefix":"10.1016","volume":"105","author":[{"given":"I.","family":"Fuertes de Vega","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Iranzo-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.M.","family":"Mascar\u00f3-Galy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ad.2012.10.022_bib0005","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.det.2011.06.003","article-title":"Evidence-based management of bullous pemphigoid","volume":"29","author":"Daniel","year":"2011","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.ad.2012.10.022_bib0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/11318600-000000000-00000","article-title":"Autoimmune bullous dermatoses in the elderly: an update on pathophysiology, diagnosis and management","volume":"1","author":"Mutasim","year":"2010","journal-title":"Drugs Aging"},{"key":"10.1016\/j.ad.2012.10.022_bib0015","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.yadr.2007.07.013","article-title":"Bullous pemphigoid: physiopathology, clinical features and management","volume":"23","author":"Di Zenzo","year":"2007","journal-title":"Adv Dermatol"},{"key":"10.1016\/j.ad.2012.10.022_bib0020","doi-asserted-by":"crossref","first-page":"319","DOI":"10.2165\/00128071-200405050-00005","article-title":"Management of bullous pemphigoid: recommendations for immunomodulatory treatments","volume":"5","author":"Kirtschig","year":"2004","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.ad.2012.10.022_bib0025","doi-asserted-by":"crossref","first-page":"a180","DOI":"10.1136\/bmj.a180","article-title":"Bullous pemphigoid and pemphigus vulgaris--incidence and mortality in the UK: population based cohort study","volume":"337","author":"Langan","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.ad.2012.10.022_bib0030","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1038\/jid.2012.35","article-title":"Incidence and mortality of bullous pemphigoid in France","volume":"132","author":"Joly","year":"2012","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ad.2012.10.022_bib0035","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1365-2133.1990.tb01447.x","article-title":"The association of bullous pemphigoid and malignant disease: a case control study","volume":"123","author":"Venning","year":"1990","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ad.2012.10.022_bib0040","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1038\/sj.jid.5700958","article-title":"A pathogenic role for IgE in autoimmunity: bullous pemphigoid IgE reproduces the early phase of lesion development in human skin grafted to nu\/nu mice","volume":"127","author":"Fairley","year":"2007","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ad.2012.10.022_bib0045","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1038\/sj.jid.5700681","article-title":"IgE basement membrane zone antibodies induce eosinophil infiltration and histological blisters in engrafted human skin on SCID mice","volume":"127","author":"Zone","year":"2007","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ad.2012.10.022_bib0050","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1001\/archderm.143.2.249","article-title":"The role of IgE anti-basement membrane zone autoantibodies in bullous pemphigoid","volume":"143","author":"Woodley","year":"2007","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.ad.2012.10.022_bib0055","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1001\/archdermatol.2007.9","article-title":"Correlation of IgE autoantibody to BP180 with a severe form of bullous pemphigoid","volume":"144","author":"Iwata","year":"2008","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.ad.2012.10.022_bib0060","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1001\/archderm.134.9.1075","article-title":"Evaluation of clinical criteria for diagnosis of bullous pemphigoid. French Bullous Study Group","volume":"134","author":"Vaillant","year":"1998","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.ad.2012.10.022_bib0065","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1471-5945-4-10","article-title":"Enhanced diagnostic immunofluorescence using biopsies transported in saline","volume":"4","author":"Vodegel","year":"2004","journal-title":"BMC Dermatol"},{"issue":"Suppl 1","key":"10.1016\/j.ad.2012.10.022_bib0070","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1159\/000246955","article-title":"A retrospective analysis of tissue-fixed immunoreactants from skin biopsies maintained in Michel's medium","volume":"189","author":"Vaughan Jones","year":"1994","journal-title":"Dermatology"},{"key":"10.1016\/j.ad.2012.10.022_bib0075","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1365-2133.2004.06006.x","article-title":"U-serrated immunodeposition pattern differentiates type VII collagen targeting bullous diseases from other subepidermal bullous autoimmune diseases","volume":"151","author":"Vodegel","year":"2004","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ad.2012.10.022_bib0080","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/0190-9622(91)70151-Q","article-title":"Direct immunofluorescence microscopy of 1mol\/L sodium chloride-treated patient skin","volume":"24","author":"Domloge-Hultsch","year":"1991","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2012.10.022_bib0085","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/00005792-195302000-00001","volume":"32","author":"Lever","year":"1953","journal-title":"Medicine"},{"key":"10.1016\/j.ad.2012.10.022_bib0240","article-title":"Mortality of bullous pemphigoid in the first year after diagnosis: a retrospective study in a Spanish medical centre","author":"Gual","year":"2012","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ad.2012.10.022_bib0095","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1001\/jama.284.3.350","article-title":"Pemphigoid: clinical, histologic, immuno-pathologic, and therapeutic considerations","volume":"284","author":"Yancey","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.ad.2012.10.022_bib0100","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0001-7310(08)74715-X","article-title":"Practical management of the most common autoimmune bullous diseases","volume":"99","author":"Su\u00e1rez-Fern\u00e1ndez","year":"2008","journal-title":"Actas Dermosifiliogr"},{"key":"10.1016\/j.ad.2012.10.022_bib0105","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/S0190-9622(89)70058-X","article-title":"Treatment of bullous pemphigoid with topical clobetasol propionate","volume":"20","author":"Westerhof","year":"1989","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2012.10.022_bib0110","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1056\/NEJMoa011592","article-title":"A comparison of oral and topical corticosteroids in patients with bullous pemphigoid","volume":"346","author":"Joly","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ad.2012.10.022_bib0115","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/00000372-200306000-00001","article-title":"Childhood bullous pemphigoid: a clinicopathologic study and review of the literature","volume":"25","author":"Fisler","year":"2003","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.ad.2012.10.022_bib0120","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.jaad.2011.06.032","article-title":"Definitions and outcome measures for bullous pemphigoid: recommendations by an international panel of experts","volume":"66","author":"Murrell","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2012.10.022_bib0125","first-page":"4","article-title":"Introducing a novel Autoimmune Bullous Skin Disorder Intensity Score (ABSIS) in pemphigus","volume":"17","author":"Pf\u00fctze","year":"2007","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.ad.2012.10.022_bib0130","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1159\/000324899","article-title":"Management of bullous pemphigoid with topical steroids in the clinical practice of a single center: outcome at 6 and 12 months","volume":"222","author":"Ingen-Housz-Oro","year":"2011","journal-title":"Dermatology"},{"key":"10.1016\/j.ad.2012.10.022_bib0135","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1038\/jid.2008.412","article-title":"A comparison of two regimens of topical corticosteroids in the treatment of patients with bullous pemphigoid: a multicenter randomized study","volume":"129","author":"Joly","year":"2009","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ad.2012.10.022_bib0140","first-page":"925","article-title":"Treatment of bullous pemphigoid with prednisolone only: 0.75mg\/kg\/day versus 1.25mg\/kg\/day. A multicenter randomized study","volume":"111","author":"Morel","year":"1984","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.ad.2012.10.022_bib0145","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1001\/archderm.1994.01690060083010","article-title":"Nicotinamide and tetracycline therapy of bullous pemphigoid","volume":"130","author":"Fivenson","year":"1994","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.ad.2012.10.022_bib0150","first-page":"19","article-title":"Dapsone for the treatment of bullous pemphigoid","volume":"1","author":"Phiamphonsongant","year":"1983","journal-title":"Asian Pacific J Allergy Immunol"},{"key":"10.1016\/j.ad.2012.10.022_bib0155","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1365-2133.1989.tb07769.x","article-title":"Dapsone as first line therapy for bullous pemphigoid","volume":"120","author":"Venning","year":"1989","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ad.2012.10.022_bib0160","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S0190-9622(96)80085-5","article-title":"Treatment of bullous pemphigoid with dapsone: retrospective study of thirty-six cases","volume":"34","author":"Bouscarat","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2012.10.022_bib0165","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1001\/archderm.1977.01640050070009","article-title":"Bullous pemphigoid responding to sulfapyridine and the sulfones","volume":"113","author":"Person","year":"1977","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.ad.2012.10.022_bib0170","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S0190-9622(99)70156-8","article-title":"Low-dose oral pulse methotrexate as monotherapy in elderly patients with bullous pemphigoid","volume":"40","author":"Heilborn","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2012.10.022_bib0175","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1001\/archderm.138.9.1255","article-title":"Treatment of bullous pemphigoid by low-dose methotrexate associated with short-term potent topical steroids: an open study of 18 cases","volume":"138","author":"Dereure","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.ad.2012.10.022_bib0180","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1136\/bmj.2.6146.1190","article-title":"Azathioprine plus prednisone in treatment of pemphigoid","volume":"28","author":"Burton","year":"1978","journal-title":"Br Med J"},{"key":"10.1016\/j.ad.2012.10.022_bib0185","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1001\/archderm.1993.01680220061016","article-title":"Controlled trial of azathioprine and plasma exchange in addition to prednisolone in the treatment of bullous pemphigoid","volume":"129","author":"Guillaume","year":"1993","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.ad.2012.10.022_bib0190","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0190-9622(99)70084-8","article-title":"Mycophenolate mofetil: a new therapeutic option in the treatment of blistering autoimmune diseases","volume":"40","author":"Grundmann-Kollmann","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2012.10.022_bib0195","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1001\/archderm.143.12.1536","article-title":"A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of bullous pemphigoid","volume":"143","author":"Beissert","year":"2007","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.ad.2012.10.022_bib0200","first-page":"143","article-title":"Dexamethasone-cyclophosphamide pulse therapy in bullous autoimmune dermatoses","volume":"44","author":"Appelhans","year":"1993","journal-title":"Hautarzt"},{"key":"10.1016\/j.ad.2012.10.022_bib0205","first-page":"1223","article-title":"Immediate treatment of bullous pemphigus with a corticosteroid-cyclophosphamide combination","volume":"113","author":"Ta\u00efeb","year":"1986","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.ad.2012.10.022_bib0210","doi-asserted-by":"crossref","first-page":"3440","DOI":"10.1172\/JCI24394","article-title":"Complete FcRn dependence for intravenous Ig therapy in autoimmune skin blistering diseases","volume":"115","author":"Li","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ad.2012.10.022_bib0215","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1067\/mjd.2001.116337","article-title":"Intravenous immunoglobulin therapy for patients with bullous pemphigoid unresponsive to conventional immunosuppressive treatment","volume":"45","author":"Ahmed","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2012.10.022_bib0220","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1111\/j.1468-3083.2010.03889.x","article-title":"Bullous and mucous membrane pemphigoid show a mixed response to rituximab: experience in seven patients","volume":"25","author":"Lourari","year":"2011","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ad.2012.10.022_bib0225","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/j.1365-2133.2006.07646.x","article-title":"Rituximab in autoimmune bullous diseases: mixed responses and adverse effects","volume":"156","author":"Schmidt","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ad.2012.10.022_bib0230","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/S0140-6736(84)92565-0","article-title":"Plasma exchange in bullous pemphigoid","volume":"2","author":"Roujeau","year":"1984","journal-title":"Lancet"},{"key":"10.1016\/j.ad.2012.10.022_bib0235","first-page":"CD002292","article-title":"Interventions for bullous pemphigoid","volume":"6","author":"Kirtschig","year":"2010","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001731013000367?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001731013000367?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T01:01:25Z","timestamp":1757552485000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001731013000367"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":47,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S0001731013000367"],"URL":"https:\/\/doi.org\/10.1016\/j.ad.2012.10.022","relation":{},"ISSN":["0001-7310"],"issn-type":[{"value":"0001-7310","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Penfigoide ampolloso: gu\u00eda de manejo pr\u00e1ctico","name":"articletitle","label":"Article Title"},{"value":"Actas Dermo-Sifiliogr\u00e1ficas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ad.2012.10.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Espa\u00f1a, S.L. y AEDV. All rights reserved.","name":"copyright","label":"Copyright"}]}}